D-0010-2027 Class II Ongoing
FDA drug recall D-0010-2027 was initiated by Ajanta Pharma USA Inc on Sep 17, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications: below specification The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 7, 2026
- Initiation Date
- Sep 17, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Reason for recall
Failed Dissolution Specifications: below specification
Distribution pattern
Nationwide in the US.
Code information
Lot: DJ25134, Exp 11/30/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0010-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026